This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Harvard suffers fresh defeat at UPC in patent fight with NanoString over genetic imaging technology

By Melissa Ritti ( October 17, 2024, 15:01 GMT | Insight) -- A Harvard-owned patent licensed exclusively to 10X Genomics was revoked in its entirety today in Germany, the Netherlands and France. The Unified Patent Court Central Division at Munich delivered a win to NanoString Technologies Europe Limited in global litigation over spatial multi-omics used for gene editing while also renewing its proclamation of international jurisdiction.NanoString Technologies Europe Limited, maker of the CosMx single cell imaging platform, has prevailed on its challenge before the Unified Patent Court of a President and Fellows of Harvard College patent....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login